(Q46425552)

English

Fluorescence in situ hybridization monitoring of BCR-ABL-positive neutrophils in chronic-phase chronic myeloid leukemia patients during the primary stage of imatinib mesylate therapy

scientific article published in April 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15814334

Fluorescence in situ hybridization monitoring of BCR-ABL-positive neutrophils in chronic-phase chronic myeloid leukemia patients during the primary stage of imatinib mesylate therapy (English)

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15814334

chronic myeloid leukemia

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Naoto Takahashi

1

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15814334

Ikuo Miura

2

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15814334

Yoshimi Kobayashi

3

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15814334

Masaaki Kume

4

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15814334

Tomoko Yoshioka

5

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15814334

Wataru Otane

6

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15814334

Kaori Ohtsubo

7

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15814334

Kaoru Takahashi

8

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15814334

Atsushi Kitabayashi

9

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15814334

Yoshinari Kawabata

10

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15814334

Makoto Hirokawa

11

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15814334

Hirokazu Nishijima

12

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15814334

Ryo Ichinohasama

13

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15814334

John Decoteau

14

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15814334

Akira B Miura

15

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15814334

Ken-Ichi Sawada

16

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15814334

publication date

1 April 2005

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15814334

International Journal of Hematology

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15814334

81

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15814334

3

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15814334

235-241

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15814334

https://scigraph.springernature.com/pub.10.1532/ijh97.04095

0 references

Practical management of patients with chronic myeloid leukemia receiving imatinib

1 reference

https://pubmed.ncbi.nlm.nih.gov/15814334

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Early detection of BCR-ABL transcripts by quantitative reverse transcriptase-polymerase chain reaction predicts outcome after allogeneic stem cell transplantation for chronic myeloid leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/15814334

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantitative reverse transcription polymerase chain reaction should not replace conventional cytogenetics for monitoring patients with chronic myeloid leukemia during early phase of imatinib therapy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15814334

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The early molecular response to imatinib predicts cytogenetic and clinical outcome in chronic myeloid leukaemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/15814334

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monitoring chronic myeloid leukaemia therapy by real-time quantitative PCR in blood is a reliable alternative to bone marrow cytogenetics

1 reference

https://pubmed.ncbi.nlm.nih.gov/15814334

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Molecular heterogeneity in complete cytogenetic responders after interferon-alpha therapy for chronic myelogenous leukemia: low levels of minimal residual disease are associated with continuing remission. German CML Study Group and the UK MRC CML St

1 reference

https://pubmed.ncbi.nlm.nih.gov/15814334

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Emergence of clonal cytogenetic abnormalities in Ph- cells in some CML patients in cytogenetic remission to imatinib but restoration of polyclonal hematopoiesis in the majority

1 reference

https://pubmed.ncbi.nlm.nih.gov/15814334

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A special fluorescent in situ hybridization technique to study peripheral blood and assess the effectiveness of interferon therapy in chronic myeloid leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/15814334

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Early reduction of BCR-ABL mRNA transcript levels predicts cytogenetic response in chronic phase CML patients treated with imatinib after failure of interferon alpha

1 reference

https://pubmed.ncbi.nlm.nih.gov/15814334

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fluorescence in situ hybridization for the detection and monitoring of the Ph-positive clone in chronic myelogenous leukemia: comparison with metaphase banding analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/15814334

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Correlations of chromosome abnormalities with histologic and immunologic characteristics in 49 patients from Akita, Japan with non-Hodgkin lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/15814334

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficiency of interphase fluorescence in situ hybridization for BCR/ABL on peripheral blood smears for monitoring of CML patients: a comparison with bone marrow findings

1 reference

https://pubmed.ncbi.nlm.nih.gov/15814334

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lineage involvement of stem cells bearing the philadelphia chromosome in chronic myeloid leukemia in the chronic phase as shown by a combination of fluorescence-activated cell sorting and fluorescence in situ hybridization

1 reference

https://pubmed.ncbi.nlm.nih.gov/15814334

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Correlation of three methods of measuring cytogenetic response in chronic myelocytic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/15814334

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fluorescence in situ hybridization on peripheral-blood specimens is a reliable method to evaluate cytogenetic response in chronic myeloid leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/15814334

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical investigation of human alpha interferon in chronic myelogenous leukemia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15814334

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15814334

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Molecular cytogenetics of stem cells: target cells of chromosome aberrations as revealed by the application of fluorescence in situ hybridization to fluorescence-activated cell sorting.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15814334

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interferon-alpha produces sustained cytogenetic responses in chronic myelogenous leukemia. Philadelphia chromosome-positive patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/15814334

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term follow-Up of the italian trial of interferon-alpha versus conventional chemotherapy in chronic myeloid leukemia. The Italian Cooperative Study Group on Chronic Myeloid Leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/15814334

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

FISH for BCR-ABL on interphases of peripheral blood neutrophils but not of unselected white cells correlates with bone marrow cytogenetics in CML patients treated with imatinib

1 reference

https://pubmed.ncbi.nlm.nih.gov/15814334

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Proposal for a simple synthesis prognostic staging system in chronic myelogenous leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/15814334

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fluorescence in situ hybridization (FISH) on peripheral blood smears for monitoring Philadelphia chromosome-positive chronic myeloid leukemia (CML) during interferon treatment: a new strategy for remission assessment

1 reference

https://pubmed.ncbi.nlm.nih.gov/15814334

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detection of the BCR-ABL gene by interphase fluorescence in situ hybridization (iFISH) in chronic myelogenous leukemia patients after hemopoietic stem cell transplantation: the feasibility of iFISH monitoring of therapeutic response in peripheral bl

1 reference

https://pubmed.ncbi.nlm.nih.gov/15814334

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fluorescent in situ hybridization studies of lymphocytes and neutrophils in chronic granulocytic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/15814334

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detection of BCR-ABL mutations in patients with CML treated with imatinib is virtually always accompanied by clinical resistance, and mutations in the ATP phosphate-binding loop (P-loop) are associated with a poor prognosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/15814334

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/15814334

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/15814334

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Simple and reliably sensitive diagnosis and monitoring of Philadelphia chromosome-positive cells in chronic myeloid leukemia by interphase fluorescence in situ hybridization of peripheral blood cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/15814334

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/15814334

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantitative polymerase chain reaction monitoring of BCR-ABL during therapy with imatinib mesylate (STI571; gleevec) in chronic-phase chronic myelogenous leukemia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15814334

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1532/IJH97.04095

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15814334

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15814334

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46425552&oldid=2111053025"